High mobility group box 1 (HMGB1) acts as an “alarmin” to promote acute myeloid leukaemia progression

• Yasinska, Inna M. Medway School of Pharmacy, Universities of Kent and Greenwich, Chatham Maritime, United Kingdom
• Gonçalves Silva, Isabel Medway School of Pharmacy, Universities of Kent and Greenwich, Chatham Maritime, United Kingdom
• Sakhnevych, Svetlana S. Medway School of Pharmacy, Universities of Kent and Greenwich, Chatham Maritime, United Kingdom
• Ruegg, Laura Medway School of Pharmacy, Universities of Kent and Greenwich, Chatham Maritime, United Kingdom
• Hussain, Rohanah Beamline 23, Diamond Light Source, Didcot, UK
• Siligardi, Giuliano Beamline 23, Diamond Light Source, Didcot, UK
• Fiedler, Walter Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, Germany
• Wellbrock, Jasmin Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, Germany
• Bardelli, Marco Institute for Research in Biomedicine, Universita' della Svizzera italiana (USI), Bellinzona, Switzerland
• Varani, Luca Institute for Research in Biomedicine, Universita' della Svizzera italiana (USI), Bellinzona, Switzerland
• Raap, Ulrike Department of Medicine (Dermatology and Allergology), University of Oldenburg, Germany
• Berger, Steffen Department of Pediatric Surgery and Department of Biomedical Research, Children's Hospital, Inselspital, University of Bern, Switzerland
• Gibbs, Bernhard F. Department of Medicine (Dermatology and Allergology), University of Oldenburg, Germany
• Fasler-Kan, Elizaveta Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland
• Sumbayev, Vadim V. Medway School of Pharmacy, Universities of Kent and Greenwich, Chatham Maritime, United Kingdom

Immunology

Immunology and Allergy

Oncology